Oppenheimer & CO Inc Ark Genomic Revolution ETF (De Transaction History
Oppenheimer & CO Inc
- $7.23 Billion
- Q2 2025
A detailed history of Oppenheimer & CO Inc transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Oppenheimer & CO Inc holds 19,816 shares of ARKG stock, worth $463,298. This represents 0.01% of its overall portfolio holdings.
Number of Shares
19,816
Previous 18,663
6.18%
Holding current value
$463,298
Previous $387,000
24.55%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ARKG
# of Institutions
275Shares Held
18.9MCall Options Held
4.63MPut Options Held
3.85M-
Jpmorgan Chase & CO New York, NY3.43MShares$80.3 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY3.29MShares$76.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.37MShares$55.3 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.2MShares$28.2 Million0.0% of portfolio
-
State Of Wisconsin Investment Board Madison, WI962KShares$22.5 Million0.05% of portfolio